Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Stojković, Mirjana (7006722691)"

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Biochemical and clinical characteristics of patients with primary aldosteronism-Single centre experience Biohemijske i kliničke karakteristike pacijenata sa primarnim aldosteronizmom-Iskustvo jednog centra
    (2020)
    Vujačić, Nataša (57211011760)
    ;
    Paunović, Ivan (55990696700)
    ;
    Diklić, Aleksandar (6601959320)
    ;
    Å Ivaljević, Vladan (57211012161)
    ;
    Slijepčević, Nikola (35811197900)
    ;
    Kalezić, Nevena (6602526969)
    ;
    Stojković, Mirjana (7006722691)
    ;
    Stojanović, Miloš (58202803500)
    ;
    Beleslin, Biljana (6701355427)
    ;
    Å Arković, Miloš (57211013098)
    ;
    Ć Irić, Jasmina (57211011691)
    Primary aldosteronism (PA) is associated with increased prevalence of metabolic disorders (impaired glucose and lipid metabolism and insulin resistance), but also with more frequent cardiovascular, renal and central nervous system complications. Biochemical and clinical parameters were retrospectively analysed for 40 patients with PA caused by aldosterone-producing adenoma (APA) and compared to the control groups of 40 patients with nonfunctioning adrenal adenoma (NFA) and essential hypertension (HT), and 20 patients with adrenal Cushing syndrome (CS) or subclinical CS (SCS). Systolic, diastolic and mean arterial blood pressures were significantly higher in the PA group (p=0.004; p=0.002; p=0.001, respectively) than in NFA+HT group. PA patients had longer hypertension history (p=0.001) than patients with hypercorticism and all had hypokalaemia. This group showed the smallest mean tumour diameter (p<0.001). The metabolic syndrome was significantly less common in the PA group (37.5% vs. 70% in CS+SCS and 65% in NFA+HT group; p=0.015), although there was no significant difference in any of the analysed metabolic parameters between groups. PA group was found to have the most patients with glucose intolerance (81.8%), although the difference was not significant. The mean BMI for all three groups was in the overweight range. Patients with PA had higher microalbuminuria and a higher tendency for cardiovascular, renal and cerebrovascular events, but the difference was not significant. Our results support the importance of the early recognition of primary aldosteronism on the bases of clinical presentation, as well as an increased screening intensity. © 2019 © 2019.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Biochemical and clinical characteristics of patients with primary aldosteronism-Single centre experience Biohemijske i kliničke karakteristike pacijenata sa primarnim aldosteronizmom-Iskustvo jednog centra
    (2020)
    Vujačić, Nataša (57211011760)
    ;
    Paunović, Ivan (55990696700)
    ;
    Diklić, Aleksandar (6601959320)
    ;
    Å Ivaljević, Vladan (57211012161)
    ;
    Slijepčević, Nikola (35811197900)
    ;
    Kalezić, Nevena (6602526969)
    ;
    Stojković, Mirjana (7006722691)
    ;
    Stojanović, Miloš (58202803500)
    ;
    Beleslin, Biljana (6701355427)
    ;
    Å Arković, Miloš (57211013098)
    ;
    Ć Irić, Jasmina (57211011691)
    Primary aldosteronism (PA) is associated with increased prevalence of metabolic disorders (impaired glucose and lipid metabolism and insulin resistance), but also with more frequent cardiovascular, renal and central nervous system complications. Biochemical and clinical parameters were retrospectively analysed for 40 patients with PA caused by aldosterone-producing adenoma (APA) and compared to the control groups of 40 patients with nonfunctioning adrenal adenoma (NFA) and essential hypertension (HT), and 20 patients with adrenal Cushing syndrome (CS) or subclinical CS (SCS). Systolic, diastolic and mean arterial blood pressures were significantly higher in the PA group (p=0.004; p=0.002; p=0.001, respectively) than in NFA+HT group. PA patients had longer hypertension history (p=0.001) than patients with hypercorticism and all had hypokalaemia. This group showed the smallest mean tumour diameter (p<0.001). The metabolic syndrome was significantly less common in the PA group (37.5% vs. 70% in CS+SCS and 65% in NFA+HT group; p=0.015), although there was no significant difference in any of the analysed metabolic parameters between groups. PA group was found to have the most patients with glucose intolerance (81.8%), although the difference was not significant. The mean BMI for all three groups was in the overweight range. Patients with PA had higher microalbuminuria and a higher tendency for cardiovascular, renal and cerebrovascular events, but the difference was not significant. Our results support the importance of the early recognition of primary aldosteronism on the bases of clinical presentation, as well as an increased screening intensity. © 2019 © 2019.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Challenges in interpretation of thyroid hormone test results
    (2016)
    Lalić, Tijana (57189371865)
    ;
    Beleslin, Biljana (6701355427)
    ;
    Savić, Slavica (35328081800)
    ;
    Stojković, Mirjana (7006722691)
    ;
    Ćirić, Jasmina (6601995819)
    ;
    Žarković, Miloš (7003498546)
    Introduction In interpreting thyroid hormones results it is preferable to think of interference and changes in concentration of their carrier proteins. Outline of Cases We present two patients with discrepancy between the results of thyroid function tests and clinical status. The first case presents a 62-year-old patient with a nodular goiter and Hashimoto thyroiditis. Thyroid function test showed low thyroid-stimulating hormone (TSH) and normal to low fT4. By determining thyroid status (TSH, T4, fT4, T3, fT3) in two laboratories, basal and after dilution, as well as thyroxine-binding globulin (TBG), it was concluded that the thyroid hormone levels were normal. The results were influenced by heterophile antibodies leading to a false lower TSH level and suspected secondary hypothyroidism. The second case, a 40-year-old patient, was examined and followed because of the variable size thyroid nodule and initially borderline elevated TSH, after which thyroid status showed low level of total thyroid hormones and normal TSH. Based on additional analysis it was concluded that low T4 and T3 were a result of low TBG. It is a hereditary genetic disorder with no clinical significance. Conclusion Erroneous diagnosis of thyroid disorders and potentially harmful treatment could be avoided by proving the interference or TBG deficiency whenever there is a discrepancy between the thyroid function results and the clinical picture. © 2016, Serbia Medical Society. All rights reserved.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback